Traws Pharma, Inc. Increase (Decrease) in Accounts Payable
Traws Pharma, Inc. (TRAW) reported Increase (Decrease) in Accounts Payable of $534.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14
- Traws Pharma, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.48M.
- Traws Pharma, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $2.01M.
- Traws Pharma, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $2.47M, a 211.35% increase year-over-year.
- Traws Pharma, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $524.00K.
- Traws Pharma, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$612.00K, a 194.74% decline from fiscal 2024.
- Traws Pharma, Inc. increase (decrease) in accounts payable for fiscal 2024 was $646.00K, a 63.27% decline from fiscal 2023.
- Traws Pharma, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.76M, a 59.47% increase from fiscal 2022.
- Traws Pharma, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.10M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $534.00K 10-Q · filed 2026-08-14 | $3.00M derived: sum of 3 quarters · filed 2026-08-14 | $3.53M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.01M 10-Q · filed 2026-05-15 | $4.48M derived: sum of 2 quarters · filed 2026-05-15 | $5.00M derived: sum of 3 quarters · filed 2026-05-15 | $2.00M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $2.99M derived: sum of 2 quarters · filed 2026-04-15 | -$7.00K derived: sum of 3 quarters · filed 2026-08-14 | -$612.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $524.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.48M derived: sum of 2 quarters · filed 2026-08-14 | -$3.08M 10-Q · filed 2025-11-13 | -$2.29M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$3.60M 10-Q · filed 2026-08-14 | -$2.81M derived: sum of 3 quarters · filed 2026-08-14 | -$3.51M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$605.00K 10-Q · filed 2026-05-15 | $188.00K derived: sum of 2 quarters · filed 2026-05-15 | -$514.00K derived: sum of 3 quarters · filed 2026-05-15 | -$908.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $793.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $91.00K derived: sum of 2 quarters · filed 2026-04-15 | -$303.00K derived: sum of 3 quarters · filed 2026-04-15 | $646.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | -$702.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.10M derived: sum of 2 quarters · filed 2025-11-13 | -$147.00K 10-Q · filed 2025-11-13 | -$676.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $555.00K 10-Q · filed 2025-08-14 | $26.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.10M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $949.00K 10-Q · filed 2025-05-15 | $420.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.50M derived: sum of 3 quarters · filed 2025-05-15 | $1.67M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$529.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $548.00K derived: sum of 2 quarters · filed 2025-03-31 | $723.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.76M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.25M derived: sum of 2 quarters · filed 2024-11-14 | $2.29M 10-Q · filed 2024-11-14 | $2.39M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-15 | $1.21M 10-Q · filed 2024-08-15 | $1.31M derived: sum of 3 quarters · filed 2024-08-15 | $2.07M derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-03-31 | $1.04M 10-Q · filed 2024-05-15 | $1.14M derived: sum of 2 quarters · filed 2024-05-15 | $1.89M derived: sum of 3 quarters · filed 2024-05-15 | $1.77M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $857.00K derived: sum of 2 quarters · filed 2024-04-01 | $738.00K derived: sum of 3 quarters · filed 2024-04-01 | $1.10M 10-K · filed 2024-04-01 |
| 2022-09-30 | $757.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $638.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.00M 10-Q · filed 2023-11-14 | -$290.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $246.00K 10-Q · filed 2023-08-14 | -$1.05M derived: sum of 3 quarters · filed 2023-08-14 | -$1.29M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $365.00K 10-Q · filed 2023-05-15 | -$928.00K derived: sum of 2 quarters · filed 2023-05-15 | -$1.17M derived: sum of 3 quarters · filed 2023-05-15 | -$866.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.53M derived: sum of 2 quarters · filed 2023-03-30 | -$1.23M derived: sum of 3 quarters · filed 2023-03-30 | -$2.08M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $62.00K derived: sum of 2 quarters · filed 2022-11-14 | -$783.00K 10-Q · filed 2022-11-14 | -$1.68M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $302.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$543.00K 10-Q · filed 2022-08-15 | -$1.44M derived: sum of 3 quarters · filed 2022-08-15 | -$858.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$845.00K 10-Q · filed 2022-05-13 | -$1.74M derived: sum of 2 quarters · filed 2022-05-13 | -$1.16M derived: sum of 3 quarters · filed 2022-05-13 | -$195.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$892.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$315.00K derived: sum of 2 quarters · filed 2022-03-21 | $650.00K derived: sum of 3 quarters · filed 2022-03-21 | $562.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.54M derived: sum of 2 quarters · filed 2021-11-15 | $1.45M 10-Q · filed 2021-11-15 | $1.20M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $965.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $877.00K 10-Q · filed 2021-08-16 | $624.00K derived: sum of 3 quarters · filed 2021-08-16 | $398.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$88.00K 10-Q · filed 2021-05-17 | -$341.00K derived: sum of 2 quarters · filed 2021-05-17 | -$567.00K derived: sum of 3 quarters · filed 2021-05-17 | -$151.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$479.00K derived: sum of 2 quarters · filed 2021-03-18 | -$63.00K derived: sum of 3 quarters · filed 2021-03-18 | $232.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | -$226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $190.00K derived: sum of 2 quarters · filed 2020-11-16 | $485.00K 10-Q · filed 2020-11-16 | $260.00K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $711.00K 10-Q · filed 2020-08-12 | $486.00K derived: sum of 3 quarters · filed 2020-08-12 | -$1.20M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $295.00K 10-Q · filed 2020-05-15 | $70.00K derived: sum of 2 quarters · filed 2020-05-15 | -$1.61M derived: sum of 3 quarters · filed 2020-05-15 | -$2.01M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$1.91M derived: sum of 2 quarters · filed 2020-03-27 | -$2.30M derived: sum of 3 quarters · filed 2020-03-27 | -$1.45M 10-K · filed 2020-03-27 |
| 2018-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.08M derived: sum of 2 quarters · filed 2019-11-12 | -$1.23M 10-Q · filed 2019-11-12 | -$479.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $456.00K 10-Q · filed 2019-08-14 | $1.21M derived: sum of 3 quarters · filed 2019-08-14 | $961.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $848.00K 10-Q · filed 2019-05-15 | $1.60M derived: sum of 2 quarters · filed 2019-05-15 | $1.35M derived: sum of 3 quarters · filed 2019-05-15 | $1.63M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $505.00K derived: sum of 2 quarters · filed 2019-04-01 | $779.00K derived: sum of 3 quarters · filed 2019-04-01 | $863.00K 10-K · filed 2019-04-01 |
| 2017-09-30 | -$245.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $29.00K derived: sum of 2 quarters · filed 2018-11-14 | $113.00K 10-Q · filed 2018-11-14 | $1.36M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $358.00K 10-Q · filed 2018-08-14 | $1.61M derived: sum of 3 quarters · filed 2018-08-14 | $2.88M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $84.00K 10-Q · filed 2018-05-15 | $1.34M derived: sum of 2 quarters · filed 2018-05-15 | $2.61M derived: sum of 3 quarters · filed 2018-05-15 | $2.11M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $2.52M derived: sum of 2 quarters · filed 2018-03-16 | $2.03M derived: sum of 3 quarters · filed 2018-03-16 | $1.90M 10-K · filed 2018-03-16 |
| 2016-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $775.00K derived: sum of 2 quarters · filed 2017-11-09 | $650.00K 10-Q · filed 2017-11-09 | $881.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$495.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$620.00K 10-Q · filed 2017-08-14 | -$389.00K derived: sum of 3 quarters · filed 2017-08-14 | -$1.38M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$125.00K 10-Q · filed 2017-05-15 | $106.00K derived: sum of 2 quarters · filed 2017-05-15 | -$889.00K derived: sum of 3 quarters · filed 2017-05-15 | -$561.00K derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $231.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$764.00K derived: sum of 2 quarters · filed 2017-03-29 | -$436.00K derived: sum of 3 quarters · filed 2017-03-29 | -$606.00K 10-K · filed 2017-03-29 |
| 2015-09-30 | -$995.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$667.00K derived: sum of 2 quarters · filed 2016-11-14 | -$837.00K 10-Q · filed 2016-11-14 | -$2.19M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $158.00K 10-Q · filed 2016-08-15 | -$1.20M derived: sum of 3 quarters · filed 2016-08-15 | -$842.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$170.00K 10-Q · filed 2016-05-11 | -$1.53M derived: sum of 2 quarters · filed 2016-05-11 | -$1.17M derived: sum of 3 quarters · filed 2016-05-11 | $555.00K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$1.00M derived: sum of 2 quarters · filed 2016-03-28 | $725.00K derived: sum of 3 quarters · filed 2016-03-28 | $317.00K 10-K · filed 2016-03-28 |
| 2014-09-30 | $358.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.08M derived: sum of 2 quarters · filed 2015-11-12 | $1.68M 10-Q · filed 2015-11-12 | $980.00K derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.32M 10-Q · filed 2015-08-13 | $622.00K derived: sum of 3 quarters · filed 2015-08-13 | $617.00K derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | -$408.00K 10-Q · filed 2015-05-15 | -$1.10M derived: sum of 2 quarters · filed 2015-05-15 | -$1.11M derived: sum of 3 quarters · filed 2015-05-15 | -$941.00K derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | -$695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$700.00K derived: sum of 2 quarters · filed 2015-03-30 | -$533.00K derived: sum of 3 quarters · filed 2015-03-30 | -$1.81M 10-K · filed 2015-03-30 |
| 2013-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $162.00K derived: sum of 2 quarters · filed 2014-11-14 | -$1.11M 10-Q · filed 2014-11-14 | -$14.36M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | $167.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.11M 10-Q · filed 2014-08-14 | -$14.36M derived: sum of 3 quarters · filed 2015-03-30 | $1.33M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | -$1.27M 10-Q · filed 2014-05-15 | -$14.52M derived: sum of 2 quarters · filed 2015-03-30 | $1.16M derived: sum of 3 quarters · filed 2015-03-30 | |
| 2012-12-31 | -$13.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $2.44M derived: sum of 2 quarters · filed 2015-03-30 | -$97.00K 10-K · filed 2015-03-30 | |
| 2012-09-30 | $15.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $13.15M 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | -$2.53M 10-Q · filed 2013-09-06 | |||
| 2011-12-31 | $2.23M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |